SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4′-{[(2-phenylethyl)amino]methyl}-4-biphenylyl)methyl]propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: Evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain
Authors:
- David R. ThomasDTDavid R. Thomas
- Stefania FaedoSFStefania Faedo
- 1 September 2006
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 51 (3) , 566-577
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Discovery of a potent and selective 5-ht5A receptor antagonist by high-throughput chemistryBioorganic & Medicinal Chemistry Letters, 2005
- Serotonin‐induced phase advances of SCN neuronal firing in vitro: A possible role for 5‐HT5A receptors?Synapse, 2004
- Family-based association studies between 5-HT5A receptor gene and schizophreniaJournal of Psychiatric Research, 2004
- 5‐ht5B Receptor mRNA in the raphe nuclei: Coexpression with serotonin transporterSynapse, 2003
- Association of a 5-HT5A receptor polymorphism, Pro15Ser, to schizophreniaMolecular Psychiatry, 2001
- Serotonin and Drug-Induced Therapeutic Responses in Major Depression, Obsessive–Compulsive and Panic DisordersNeuropsychopharmacology, 1999
- Serotonin efflux in the rat ventral lateral geniculate nucleus assessed by fast cyclic voltammetry is modulated by 5-HT1B and 5-HT1D autoreceptorsNeuropharmacology, 1996
- Nonlinear regression using spreadsheetsTrends in Pharmacological Sciences, 1995
- Cloning and characterisation of the human 5‐HT5A serotonin receptorFEBS Letters, 1994
- Cloning and characterization of the rat 5‐HT5BreceptorFEBS Letters, 1993